Reshma Kewalramani, CEO & President at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 3,901 shares at $272.76 ($1.1M) on 2020-08-06, disclosed to the SEC on 2020-08-10.
Open-market sale of $1.1M VRTX by CEO & President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $269.11 | 152 | $41K | 3.9% |
| 2 | $270.36 | 870 | $235K | 22.2% |
| 3 | $270.36 | 870 | $235K | 22.2% |
| 4 | $271.42 | 471 | $128K | 12.1% |
| 5 | $271.42 | 471 | $128K | 12.1% |
| 6 | $272.76 | 487 |
| $133K |
| 12.6% |
| 7 | $272.76 | 487 | $133K | 12.6% |
| 8 | $273.27 | 93 | $25K | 2.4% |
| Total | $271.24 avg | 3,901 | $1.1M | 100% |
| Filing → |
| VRTX | SELL | 2024-11-12 | $7.8M | — | Filing → |
| VRTX | SELL | 2024-08-01 | $7.7M | — | Filing → |
| VRTX | SELL | 2024-07-24 | $7.6M | — | Filing → |